4 European Projects Found
Searched on 125080 European Projects
FINISHED
Cutaneous and Mucosal HIV Vaccination (CUT'HIVAC)
Start date: Jan 1, 2010, End date: Dec 31, 2015,
Despite significant effort over the past decade to design and implement new vaccines strategies against HIV, no one has met its promise to prevent infection and/or to reduce viral load until reaching eradication of the HIV reservoir. To reach this goal, a translational research is critical to propose innovative approaches for an HIV vaccine enhancing broadly cross-reactive mucosal, humoral and cel ...
Read Project
18
Partners Participants
FINISHED
European Network of HIV/AIDS Cohort Studies to Coordinate at European and International Level Clinical Research on HIV/AIDS (EuroCoord)
Start date: Jan 1, 2011, End date: Dec 31, 2015,
Over the past 15 years, EU-funded cohorts and collaborations (EuroSIDA, CASCADE and PENTA), have played a central role in developing our understanding of HIV progression and the effects of ART, enabling European expertise to contribute directly to the advances in patient diagnosis and management worldwide, and providing a continued surveillance mechanism for detection of emerging problems at a Eur ...
Read Project
26
Partners Participants
FINISHED
Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)
Start date: Apr 1, 2009, End date: Mar 31, 2014,
CHAIN is a large scale integrating project aimed to effectively and durably combat new and existing anti-HIV drug resistance in clinical settings, with a special emphasis on Eastern Europe and in heavily affected resource-poor regions in Africa. This will be achieved through our pan-European network of surveillance and basic research activities, the involvement of all main actors in the field of H ...
Read Project
28
Partners Participants
FINISHED
Paediatric European Network Treatment AIDS Laboratory Network (PENTA LABNET) (PENTA-LABNET)
Start date: May 1, 2008, End date: Jul 31, 2012,
"PENTA-LABNET(PL) is a coordination action aimed at improving the range of products and clinical use of antiretrovirals(ARVs) in HIV-infected children in resource-rich and resource-limited countries. This will be achieved through building capacity of laboratories to undertake co-ordinated studies on pharmacokinetics, pharmacodynamics and pharmacogenetics of new formulations and dosing and studies ...
Read Project
